Skip to main content

Advertisement

Log in

Expression and purification of recombinant human CCL5 and its biological characterization

  • Published:
The Protein Journal Aims and scope Submit manuscript

Abstract

C-C motif chemokine ligand 5 (CCL5) is crucial in the tumor microenvironment. It has been previously reported to act as a key role in tumor invasion and metastasis. However, the function of exogenous CCL5 in ovarian cancer has not been well-characterized. The present study attempted to express and purify recombinant CCL5 protein and investigate the exogenous CCL5 in ovarian cancer cell proliferation. The human CCL5 was amplified and inserted into the pET-30a vectors for prokaryotic expression in Escherichia coli BL21. Soluble His-CCL5 was successfully expressed with 0.1 mmol/L of isopropyl-β-D-1-tiogalactopiranoside at 25 ℃ and purified by affinity chromatography. Additionally, methyl thiazolyl tetrazolium (MTT) assay demonstrated that CCL5 promotes ovarian cancer cell proliferation; increases the phosphorylation levels of extracellular-signal-regulated kinase and mitogen-activated protein kinase/ERK kinase, and increases the mRNA levels of Jun, NF-κB2, Nras, Relb, and Traf2. Furthermore, treatment with the MEK inhibitor reduced the Jun, NF-κB2, and Traf2 mRNA levels, indicating that exogenous CCL5 increased ovarian cancer cell proliferation, through MEK/ERK pathway activation, and Jun, NF-κB2, and Traf2 expression. The present study provided primary data for further studies to discover more CCL5 functions in ovarian cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Yi EH, Lee CS, Lee JK, Lee YJ, Shin MK, Cho CH, Kang KW, Lee JW, Han W, Noh DY, Kim YN, Cho IH, Ye SK (2013) STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells. Mol Cancer Res 11(1):31–42

    Article  CAS  Google Scholar 

  2. Conlon KC, Miljkovic MD, Waldmann TA (2019) Cytokines in the treatment of cancer. J Interferon Cytokine Res 39(1):6–21

    Article  CAS  Google Scholar 

  3. Ouyang W, O’Garra A (2019) IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity 50(4):871–891

    Article  CAS  Google Scholar 

  4. Schall TJ, Bacon K, Toy KJ, Goeddel DV (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347(6294):669–671

    Article  CAS  Google Scholar 

  5. Kakinuma T, Hwang ST (2006) Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79(4):639–651

    Article  CAS  Google Scholar 

  6. Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I, Ben-Baruch A (1999) Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59(18):4681–4687

    CAS  PubMed  Google Scholar 

  7. Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y, Abe A (2001) Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 7(2):285–289

    CAS  PubMed  Google Scholar 

  8. Aldinucci D, Borghese C, Casagrande N (2020) The CCL5/CCR5 axis in cancer progression. Cancers (Basel) 12(7):1765

    Article  CAS  Google Scholar 

  9. Aldinucci D, Casagrande N (2018) Inhibition of the CCL5/CCR5 axis against the progression of gastric cancer. Int J Mol Sci 19(5):1477

    Article  Google Scholar 

  10. Zheng Y, Han GW, Abagyan R, Wu B, Stevens RC, Cherezov V, Kufareva I, Handel TM (2017) Structure of CC chemokine receptor 5 with a potent chemokine antagonist reveals mechanisms of chemokine recognition and molecular mimicry by HIV. Immunity 46(6):1005–1017e5

    Article  CAS  Google Scholar 

  11. d’Alayer J, Expert-Bezançon N, Béguin P (2007) Time- and temperature-dependent acetylation of the chemokine RANTES produced in recombinant Escherichia coli. Protein Expr Purif 55(1):9–16

    Article  Google Scholar 

  12. Webb PM, Jordan SJ (2017) Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol 41:3–14

    Article  Google Scholar 

  13. Jelovac D, Armstrong DK (2011) Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin 61(3):183–203

    Article  Google Scholar 

  14. Long H, Xie R, Xiang T, Zhao Z, Lin S, Liang Z, Chen Z, Zhu B (2012) Autocrine CCL5 signaling promotes invasion and migration of CD133 + ovarian cancer stem-like cells via NF-κB-mediated MMP-9 upregulation. Stem Cells 30(10):2309–2319

    Article  CAS  Google Scholar 

  15. Long H, Xiang T, Qi W, Huang J, Chen J, He L, Liang Z, Guo B, Li Y, Xie R, Zhu B (2015) CD133 + ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition. Oncotarget 6(8):5846–5859

    Article  Google Scholar 

  16. Zhou B, Sun C, Li N, Shan W, Lu H, Guo L, Guo E, Xia M, Weng D, Meng L, Hu J, Ma D, Chen G (2016) Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways. Int J Oncol 48(5):2087–2097

    Article  CAS  Google Scholar 

  17. GhoshalA, Ghosh SS (2015) Expression, purification, and therapeutic implications of recombinant sFRP1. Appl Biochem Biotechnol 175(4):2087–2103

    Article  Google Scholar 

  18. Xu T, Xiao M, Yu L (2021) Method for efficient soluble expression and purification of recombinant hyperactive Tn5 transposase. Protein Expr Purif 183:105866

    Article  CAS  Google Scholar 

  19. Liu W, Wang L, Zhang J, Qiao L, Liu Y, Yang X, Zhang J, Zheng W, Ma Z (2021) Purification of recombinant human chemokine CCL2 in E. coli and its function in ovarian cancer. 3 Biotech 11(1):8

    Article  Google Scholar 

  20. Chen L, Cai S, Wang JM, Huai YY, Lu PH, Chu Q (2020) BRDT promotes ovarian cancer cell growth. Cell Death Dis 11(11):1021

    Article  CAS  Google Scholar 

  21. Burotto M, Chiou VL, Lee JM, Kohn EC (2014) The MAPK pathway across different malignancies: a new perspective. Cancer 120(22):3446–3456

    Article  CAS  Google Scholar 

  22. Labrou NE (2014) Protein purification: an overview. Methods Mol Biol 1129:3–10

    Article  CAS  Google Scholar 

  23. Kimple ME, Brill AL, Pasker RL (2013) Overview of affinity tags for protein purification.Curr Protoc Protein Sci73: 9.9.1–9.9.23.

  24. Jia B, Jeon CO (2016) High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives. Open Biol 6(8):160196

    Article  Google Scholar 

  25. Wingfield PT (2015) Overview of the purification of recombinant proteins. Curr Protoc Protein Sci 80: 6.1.1–6.1.35

  26. Smith DB, Johnson KS (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67(1):31–40

    Article  CAS  Google Scholar 

  27. Harper S, Speicher DW (2011) Purification of proteins fused to glutathione S-transferase. Methods Mol Biol 681:259–280

    Article  CAS  Google Scholar 

  28. Wang SW, Wu HH, Liu SC, Wang PC, Ou WC, Chou WY, Shen YS, Tang CH (2012) CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. PLoS ONE 7(4):e35101

    Article  CAS  Google Scholar 

  29. Zazo S, González-Alonso P, Martín-Aparicio E, Chamizo C, Luque M, Sanz-Álvarez M, Mínguez P, Gómez-López G, Cristóbal I, Caramés C, García-Foncillas J, Eroles P, Lluch A, Arpí O, Rovira A, Albanell J, Madoz-Gúrpide J, Rojo F (2020) Autocrine CCL5 effect mediates trastuzumab resistance by ERK pathway activation in HER2-Positive breast cancer. Mol Cancer Ther 19(8):1696–1707

    CAS  PubMed  Google Scholar 

  30. Wu YH, Huang YF, Chen CC, Huang CY, Chou CY (2020) Comparing PI3K/Akt inhibitors used in ovarian cancer treatment. Front Pharmacol 11:206

    Article  CAS  Google Scholar 

  31. Deng Z, Sui G, Rosa PM, Zhao W (2012) Radiation-induced c-Jun activation depends on MEK1-ERK1/2 signaling pathway in microglial cells. PLoS ONE 7(5):e36739

    Article  CAS  Google Scholar 

  32. Hsu FT, Chiang IT, Kuo YC, Hsia TC, Lin CC, Liu YC, Chung JG (2019) Amentoflavone effectively blocked the tumor progression of glioblastoma via suppression of ERK/NF-κB signaling pathway. Am J Chin Med 47(4):913–931

    Article  CAS  Google Scholar 

  33. Li X, Bao C, Ma Z, Xu B, Ying X, Liu X, Zhang X (2018) Perfluorooctanoic acid stimulates ovarian cancer cell migration, invasion via ERK/NF-κB/MMP-2/-9 pathway. Toxicol Lett 294:44–50

    Article  CAS  Google Scholar 

  34. Borghi A, Verstrepen L, Beyaert R (2016) TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death. Biochem Pharmacol 116:1–10

    Article  CAS  Google Scholar 

  35. Ge QL, Liu SH, Ai ZH, Tao MF, Ma L, Wen SY, Dai M, Liu F, Liu HS, Jiang RZ, Xue ZW, Jiang YH, Sun XH, Hu YM, Zhao YX, Chen X, Tao Y, Zhu XL, Ding WJ, Yang BQ, Liu DD, Zhang XR, Teng YC (2016) RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis. Cell Death Dis 7(10):e2402

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported by grants from the Scientific and Technological Research Project of Henan Province (No. 212102310898), the Key scientific research project of Henan Province (No. 22A180017), and the research start-up fund to topnotch talents of Henan Agricultural University (No. 30500424).

Author information

Authors and Affiliations

Authors

Contributions

Z.M. and L.X. designed the study. Z.M., J.Z. and L.W. performed the experiments. Y.L., G.X. and K.C. performed systematic research of the literature. Z.M. wrote the paper. W.Z. and L.X. revised it.

Corresponding author

Correspondence to Li Xiang.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, Z., Zhang, J., Wang, L. et al. Expression and purification of recombinant human CCL5 and its biological characterization. Protein J 41, 337–344 (2022). https://doi.org/10.1007/s10930-022-10047-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10930-022-10047-8

Keywords

Navigation